The quotation should follow the neuro-oncology plan
Heidelberg University Hospital states that international self-pay cost estimates are generated only after medical documents have been reviewed by the relevant expert and a treatment offer has been defined. For glioblastoma, this matters because the same diagnosis can lead to very different resource use depending on whether the request concerns first treatment, residual disease or recurrence.
Neurosurgery or biopsy can be a major cost component
The surgical episode can differ from a stereotactic biopsy to a complex resection and may include anesthesia, intraoperative technologies, postoperative imaging, intensive monitoring and a variable inpatient stay. A generic brain-surgery figure should not be treated as the total glioblastoma treatment cost.
- Neurosurgical consultation and MRI review
- Stereotactic biopsy or tumor resection when indicated
- Anesthesia and operating-room care
- Neuro-navigation or other intraoperative support when used
- Postoperative MRI and neurologic monitoring
- Standard ward or intensive-care stay depending on the course
Neuropathology and molecular testing are part of treatment planning
Modern brain-tumor classification can require more than routine histology. Molecular or epigenetic diagnostics may be needed to refine the diagnosis and interpret treatment or clinical-trial questions. Ask whether pathology re-review, tissue handling and additional molecular tests are included in the estimate.
Radiotherapy is a planned treatment episode, not only a machine session
Radiation treatment can include specialist consultation, planning CT and MRI integration, immobilization, dosimetry, physics work, repeated treatment fractions and follow-up. If re-irradiation is being considered at recurrence, previous radiation plans and dose records need review before a meaningful estimate can be prepared.
Systemic treatment and supportive care can materially change the total
The systemic-treatment component depends on the clinical plan, previous therapy and current blood counts and organ function. The financial episode may also include anti-seizure treatment, corticosteroids, transfusions, infection treatment or rehabilitation-related needs. High-cost medicines and complications should be clarified separately in the quotation.
Recurrence can create a new financial pathway
A recurrence review is not simply a repeat of the original estimate. Current Heidelberg neuro-oncology studies include recurrent glioblastoma populations, reflecting the need to reassess surgery, systemic therapy, re-irradiation and research options after progression. A new treatment decision generally requires a new case-specific quotation.
Clinical-trial participation should not be marketed as a paid treatment package
Clinical trials are research and eligibility depends on the protocol. A center may have recruiting glioblastoma studies, but that does not mean an international patient is eligible or that every study-related or routine-care cost is covered. Ask the study team and international office which costs are research-related, which are routine treatment costs and which remain the patient's responsibility.
How Heidelberg bills international self-pay care
Heidelberg states that inpatient standard hospital services are billed through Germany's DRG system. The preliminary estimate is based on the expected treatment but the final DRG and additional charges depend on the diagnoses and procedures actually documented during the stay. The hospital requires advance payment according to the estimate and later performs final reconciliation; complications can lead to additional payment.
Questions to ask before advance payment
The safest comparison is between clearly defined treatment episodes.
- Does the estimate cover review only, biopsy, resection or the complete planned treatment sequence?
- Are neuropathology re-review and molecular diagnostics included?
- What inpatient duration is assumed after surgery?
- Are postoperative MRI and other imaging included?
- Does the radiotherapy estimate include planning and all assumed fractions?
- Which systemic medicines are included and which may be billed separately?
- How are ICU care, complications or extra hospital days handled?
- If recurrence treatment changes after review, will a new advance invoice be issued?
- Which follow-up MRI and consultations are included?
Official sources
Last source-reviewed 2026-08-30. Cost procedures and published service fees can change, so confirm current terms directly with the provider before transferring money or booking travel.
- Finance – international self-pay cost estimates and final billing — Heidelberg University Hospital ↗
- International treatment inquiry – specialist review and cost calculation — Heidelberg University Hospital ↗
- International-patient FAQ – cost estimate and DRG billing — Heidelberg University Hospital ↗
- Heidelberg Neuro-oncology Centre — Heidelberg University Hospital ↗